top of page
VACCINE PIPELINE
Calder is a preclinical-stage biopharmaceutical company with a pipeline focused on the discovery, development, and commercialization of subunit protein-stabilized vaccine bioprocesses for universal influenza headless hemagglutinin, respiratory syncytial virus (RSV), and Epstein-Barr virus EBV unmet needs.
The following pipeline outlines these three areas of focus and indication targets for these areas.
![Screenshot 2023-01-05 at 4.56.20 PM.png](https://static.wixstatic.com/media/388e0e_2c97bb14e8154de3a1cd0878e859ca27~mv2.png/v1/fill/w_75,h_42,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/Screenshot%202023-01-05%20at%204_56_20%20PM.png)
bottom of page